Study of Niraparib With Radiotherapy for Treatment of Metastatic Invasive Carcinoma of the Cervix

NCT03644342 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped A recent change in treatment landscape may make study futile

Conditions

Metastatic Carcinoma of the Cervix

Interventions

DRUG: Nirapaib

Sponsor

Michelle S Ludwig

Collaborators

[object Object]